Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
AITRICS to Participate in HIMSS USA 2023 2023-04-24 21:00
I-Mab Announces First Patient Dosed in Phase 3 Registrational Study of CD47 Antibody Lemzoparlimab in MDS in China 2023-04-24 21:00
DetectedX Launches MyImageDx Online Learning Platform for Radiology Educators at Association of University Radiologists and Society of Breast Imaging Meetings 2023-04-24 20:00
BIORCHESTRA Announces Significant Progress in Studies of BMD-001 Drug Program 2023-04-24 20:00
Four innovative drugs launched in three years, HKEX -Listed Simcere Pharmaceutical Group is on the Fast Track Toward Building an Innovation-Driven Global Pharmaceutical Company 2023-04-24 18:09
WuXi AppTec Continued Solid Growth in First-Quarter of 2023 On Top of an Exceptionally Strong Year of 2022 2023-04-24 18:03
Tibetan medicine advanced over past decade 2023-04-24 17:04
Samsung Biologics Reports First Quarter 2023 Financial Results 2023-04-24 14:51
Zylox-Tonbridge enters into strategic cooperation with Hicicare for innovative Chinese vascular guidewires solutions 2023-04-24 10:36
Bridge Biotherapeutics Receives FDA Authorization to Proceed with the First-in-Human Study of BBT-207, a 4th generation EGFR TKI 2023-04-24 10:00
Patsnap Unveils Synapse Visitor, the Latest AI-Powered Pharmaceutical Intelligence Platform 2023-04-24 08:00
ITRI Took Home Three Edison Awards(TM) in 2023 2023-04-21 19:27
ImmVira Appoints Dr. Oliver Kong as Chief Medical Officer 2023-04-21 09:06
More than ten thousand dollars send away as bonuses in the Boston Online Marathon 2023-04-20 23:00
CARsgen's CAR T-cell Candidate CT041 Achieves IND Clearance from the NMPA for the Postoperative Adjuvant Therapy of Pancreatic Cancer 2023-04-20 20:50
Samyang Holdings Enters Partnership with LG Chem for the Development of Innovative Cancer Therapeutics 2023-04-20 20:30
CBC GROUP AND MUBADALA CO-LEAD US$315 MILLION FUNDRAISING ROUND FOR HASTEN BIOPHARMA 2023-04-20 13:00
Innovent Announces Overall Survival Results of Phase 2 Study of Pemazyre® (pemigatinib) in Chinese Patients with Advanced Cholangiocarcinoma Presented at AACR Annual Meeting 2023 2023-04-20 08:00
500 women join Australia's landmark maternity medical device study 2023-04-19 21:08
Crystal Pharmatech's CDMO Business Unit - Crystal Formulation Services Received China Drug Product Manufacturing License, Achieving the Important Milestone in Formulation Capability 2023-04-19 21:00
1 102 103 104 105 106 812